BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24029705)

  • 1. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence.
    Shigaki K; Mitomi H; Fujimori T; Ichikawa K; Tomita S; Imura J; Fujii S; Itabashi M; Kameoka S; Sahara R; Takenoshita S
    Hum Pathol; 2013 Nov; 44(11):2393-9. PubMed ID: 24029705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
    Sato A; MacHinami R
    Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
    van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
    Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors. Association with survivin and bcl-2.
    Mikami T; Yoshida T; Akino F; Motoori T; Yajima M; Okayasu I
    Am J Clin Pathol; 2003 May; 119(5):723-30. PubMed ID: 12760292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis.
    Gushima M; Hirahashi M; Matsumoto T; Fujita K; Ohuchida K; Oda Y; Yao T; Iida M; Tsuneyoshi M
    Histopathology; 2011 Sep; 59(3):460-9. PubMed ID: 22034886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry.
    Kobayashi S; Fujimori T; Mitomi H; Tomita S; Ichikawa K; Imura J; Fujii S; Itabashi M; Kameoka S; Igarashi Y
    Diagn Pathol; 2014 May; 9():99. PubMed ID: 24886509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
    Maruyama K; Saigusa N; Baba S; Kino I
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of REG Iα expression in ulcerative colitis-associated neoplastic lesions.
    Tanaka H; Fukui H; Fujii S; Sekikawa A; Yamagishi H; Ichikawa K; Tomita S; Imura J; Yasuda Y; Chiba T; Fujimori T
    Digestion; 2011; 83(3):204-9. PubMed ID: 21266817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
    B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
    Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt pathway-related gene expression during malignant progression in ulcerative colitis.
    van Dekken H; Wink JC; Vissers KJ; Franken PF; Ruud Schouten W; J Hop WC; Kuipers EJ; Fodde R; Janneke van der Woude C
    Acta Histochem; 2007; 109(4):266-72. PubMed ID: 17445872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overexpressed p53 protein and cell-proliferative activity disappear or remarkably decrease in neoplastic CGA-positive endocrine and Paneth cells in cancer or dysplasia of ulcerative colitis].
    Matsuda K; Watanabe H; Ohta T; Ajioka Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 Dec; 92(12):1922-8. PubMed ID: 8558776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of patients with developing ulcerative colitis-associated neoplasia by nitrative DNA damage marker 8-nitroguanin expression in rectal mucosa.
    Saigusa S; Araki T; Tanaka K; Hashimoto K; Okita Y; Fujikawa H; Okugawa Y; Toiyama Y; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    J Clin Gastroenterol; 2013 Oct; 47(9):e80-6. PubMed ID: 23632356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
    Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
    Wang WC; Wu TT; Chandan VS; Lohse CM; Zhang L
    Hum Pathol; 2011 Oct; 42(10):1430-7. PubMed ID: 21420715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.